CDKN2A and neoplasm: We tested the effects of tumor-specific Atm loss by comparing these mice with their littermate controls with intact Atm with the genotype NestinTVA p21–/– Ink4A/ARFfl/fl Atmfl/fl (nIp21Afl/+) (Figure 5A).